Phthalimide Derivative Shows Anti-angiogenic Activity in a 3D Microfluidic Model and No Teratogenicity in Zebrafish Embryos
Angiogenesis is a crucial event for tumor progression and metastasis. It is the process through which new blood vessels are formed and has become a therapeutic target in many cancer therapies. However, current anti-angiogenic drugs such as Thalidomide still have detrimental teratogenic effects. This...
Saved in:
Main Authors: | Annalisa Mercurio (Author), Lucy Sharples (Author), Filomena Corbo (Author), Carlo Franchini (Author), Angelo Vacca (Author), Alessia Catalano (Author), Alessia Carocci (Author), Roger D. Kamm (Author), Andrea Pavesi (Author), Giulia Adriani (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Benzothiazole-Phthalimide Hybrids as Anti-Breast Cancer and Antimicrobial Agents
by: Alexia Barbarossa, et al.
Published: (2023) -
notch3 is essential for oligodendrocyte development and vascular integrity in zebrafish
by: Andreas Zaucker, et al.
Published: (2013) -
Morphological, teratogenic and behavioral evaluations of Gelidium spinosum methanol extract on zebrafish embryos
by: Warsi Warsi, et al.
Published: (2024) -
Replacing the phthalimide core in thalidomide with benzotriazole
by: Mikhail Krasavin, et al.
Published: (2022) -
Comparison of effects of anti-angiogenic agents in the zebrafish efficacy–toxicity model for translational anti-angiogenic drug discovery
by: Chimote G, et al.
Published: (2014)